Related Experiment Videos
Can inhibition of the renin-angiotensin system have a cardioprotective effect?
Abstract:
The inhibition of the renin-angiotensin system (RAS) has important effects on different parameters of left ventricular function. Chronic inhibition of the RAS avoids hypokalemia and potassium losses by increasing aldosterone release. This potassium-sparing effect is likely to prevent cardiac arrhythmia. Inhibition of the RAS reverses cardiac hypertrophy in renovascular and in spontaneously hypertensive rats (SHR), but not in DOCA salt hypertensive rats. Inhibition of the RAS also reverses the decrease in myocardial contractility, as demonstrated by the reversion of isoenzyme profile of cardiac myosin in renovascular hypertensive rats. In DOCA salt hypertensive rats, RAS inhibition has no effect on blood pressure or on cardiac contractility. Despite its peripheral vasodilatory property, inhibition of the RAS does not increase heart rate in relation to a direct negative chronotropic effect of angiotensin II inhibition and to the absence of activation of the baroreflex system. When RAS is activated, its inhibition has a coronary vasodilatory effect, but this coronary vasodilation is associated with a decrease in perfusion pressure and with an increase in intrinsic cardiac contractility. These concomitant effects lead us to conclude that inhibition of RAS probably has no important beneficial effect on the oxygen demand/oxygen supply ratio in the myocardium distal to the coronary artery stenosis.
Insights
Inhibiting the renin-angiotensin system (RAS) helps prevent potassium loss and cardiac issues. However, its benefits on cardiac function and blood pressure vary depending on the type of hypertension.
Area of Science:
- Cardiovascular Physiology
- Pharmacology
Background:
- The renin-angiotensin system (RAS) significantly influences left ventricular function.
- Chronic RAS inhibition can prevent hypokalemia and cardiac arrhythmias by sparing potassium.
Purpose of the Study:
- To investigate the effects of RAS inhibition on cardiac function and hemodynamics in different models of hypertension.
- To determine the impact of RAS inhibition on myocardial contractility and coronary circulation.
Main Methods:
- Studies involved renovascular hypertensive rats, spontaneously hypertensive rats (SHR), and DOCA salt hypertensive rats.
- Assessment of left ventricular function, cardiac hypertrophy, myocardial contractility, and coronary vasodilation.
- Evaluation of heart rate response and baroreflex system activation.
Main Results:
- RAS inhibition reversed cardiac hypertrophy in renovascular and SHR models, but not in DOCA salt hypertensive rats.
- Myocardial contractility improved in renovascular hypertensive rats, with no change in DOCA salt hypertensive rats.
- RAS inhibition did not increase heart rate and had a complex effect on myocardial oxygen supply/demand in stenosed coronary arteries.
Conclusions:
- RAS inhibition offers benefits like potassium retention but its effects on cardiac function are model-dependent.
- Inhibition of RAS may not significantly improve myocardial oxygen balance in conditions of coronary artery stenosis.
- The impact of RAS inhibition on cardiac contractility and blood pressure varies, with no effect observed in DOCA salt hypertensive rats.